Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q2 2019 Earnings

1MayConfirmed

Q3 2018

Q4 2018

Q1 2019

Q2 2019

-0.59

-0.54

-0.5

-0.45

Details

Expected EPS

-0.52

Actual EPS

-0.59

Surprise EPS

-0.07

Surprise Percent

+13.46%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.59 per share for Q2 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.